id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-1327-0008,FDA,FDA-2020-E-1327,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,,2022-08-29T17:28:24Z,,0,0,09000064852878d5
FDA-2020-E-1327-0007,FDA,FDA-2020-E-1327,Letter to U S Patent and Trademark Office,Other,Letter(s),2022-08-01T04:00:00Z,2022,8,2022-08-01T04:00:00Z,,2022-08-01T13:17:41Z,,0,0,090000648520026f
FDA-2020-E-1327-0006,FDA,FDA-2020-E-1327,Determination of Regulatory Review Period for Purposes of Patent Extension; ADAKVEO,Notice,Determinations,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,2022-01-04T04:59:59Z,2021-11-09T19:40:14Z,2021-24070,0,0,0900006484e18049
FDA-2020-E-1327-0005,FDA,FDA-2020-E-1327,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-10-22T04:00:00Z,2021,10,2021-10-22T04:00:00Z,,2021-10-26T14:37:08Z,,0,0,0900006484c0fa26
FDA-2020-E-1327-0004,FDA,FDA-2020-E-1327,Patent Term Extension Letter from Office of Patent Legal Administration to FDA CDER,Other,Letter(s),2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T17:27:38Z,,0,0,0900006484c0f931
FDA-2020-E-1327-0003,FDA,FDA-2020-E-1327,Patent Term Extension letter from FDA CDER to The Honorable Andrei Lancu,Other,Extension of Time,2020-07-15T04:00:00Z,2020,7,2020-07-15T04:00:00Z,,2020-07-15T19:35:03Z,,0,0,090000648475b1a2
FDA-2020-E-1327-0001,FDA,FDA-2020-E-1327,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,,2020-04-30T16:41:04Z,,0,0,0900006484522f72
FDA-2020-E-1327-0002,FDA,FDA-2020-E-1327,"Patent Term Extension Application for ADAKVEO Patent No 8,377,440",Other,Application,2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,,2020-04-30T16:42:08Z,,0,0,0900006484523ff3